Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell.
Current seasonal influenza vaccines mainly target a different, more abundant influenza surface protein called hemagglutinin (HA). However, because influenza vaccines offer varying and sometimes limited protection, scientists are exploring ways to improve vaccine effectiveness. The new research builds on previous studies of NA and was conducted by a team of scientists including investigators from the Centers of Excellence for Influenza Research and Surveillance (CEIRS)program, which is organized and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Investigators analyzed blood samples from people vaccinated against influenza and people diagnosed with either the 2009 H1N1 influenza virus or H3N2 influenza viruses. The volunteers were recruited for this study or had taken part in prior influenza research studies. The analyses indicate that influenza vaccines rarely induce NA-reactive antibodies, whereas natural influenza infection induces these types of antibodies at least as often as they induce HA-reactive antibodies. Additional studies in mice reinforced the human data, indicating that current influenza vaccines do not induce NA-reactive antibodies efficiently.
Additional laboratory experiments show that the NA-reactive antibodies induced during natural influenza infection are broadly reactive, meaning they could potentially protect against diverse strains of influenza. To test this theory, scientists isolated NA-reactive monoclonal antibodies from the H3N2 and H1N1 influenza patients (N2-reactive antibodies and N1-reactive antibodies, respectively). They administered 13 N2-reactive antibodies to mice and subsequently infected the mice with a different H3N2 virus strain. Eleven of the 13 N2-reactive antibodies partially or fully protected the mice. They also administered eight N1-reactive antibodies to mice and subsequently infected the mice with a similar H1N1 virus strain or an H5N1-like virus strain. Four of the eight antibodies completely protected the mice against both virus strains.
The authors note that the findings suggest that influenza vaccines should be optimized to better target NA for broad protection against diverse influenza strains. In this regard, NIAID is supporting research to characterize NA responses in infected and vaccinated individuals and to determine the mechanism of action of NA protection. NIAID also supports “NAction!” a CEIRS working group that identifies knowledge gaps in our understanding of NA and sets NA research priorities for improved influenza vaccines. These efforts contribute to NIAID’s larger plan to develop a universal influenza vaccine—a vaccine that can durably protect all age groups against multiple influenza virus strains.
The Latest on: Influenza
via Google News
The Latest on: Influenza
- Jamaica on Influenza Alert on February 18, 2019 at 12:52 pm
KINGSTON, Jamaica, Monday February 18, 2019 – The Ministry of Health has placed Jamaica on influenza alert in light of the significant increase in the number of cases of fever and respiratory illnesse... […]
- Update: Nine Confirmed Cases Of Equine Influenza At WEC (Views: 1) on February 18, 2019 at 11:18 am
Officials at the World Equestrian Center confirmed a total of nine cases of Equine Influenza at the Wilmington, Ohio, horse show venue on Feb. 15. This comes after three horses tested positive for the ... […]
- Influenza and the common cold – two different diseases on February 18, 2019 at 5:23 am
There is a lack of information about the difference between influenza and the common cold. Most people struggle to distinguish between these two conditions, and this often leads to irritation and ... […]
- Assessing the Dynamics and Control of Droplet- and Aerosol-Transmitted Influenza Using an Indoor Positioning System on February 18, 2019 at 2:24 am
There is increasing evidence that aerosol transmission is a major contributor to the spread of influenza. Despite this, virtually all studies assessing the dynamics and control of influenza assume tha... […]
- Pregnant Women at Higher Risk for Influenza-Associated Hospitalization on February 17, 2019 at 2:18 pm
Women who are pregnant face a higher risk of influenza-related hospitalization, no matter the trimester, new research has found. Investigators from New Zealand, partnering with colleagues from the CDC ... […]
- Influenza Medication market illuminated by new report on February 14, 2019 at 9:43 pm
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods ... […]
- Wisconsin influenza rates remain below last year's records on February 14, 2019 at 8:42 pm
LA CROSSE, Wis. (WEAU/WSAW) -- Last year was a record-breaking year in Wisconsin for the flu, with over 20,000 recorded cases. While this season has not been as disruptive as last, it is starting to p... […]
- Ask the doctors: Study shows influenza linked to increased heart attack risk on February 14, 2019 at 10:40 am
Dear Doctor: Last year, my best friend, who was home in bed with a bad case of the flu, died of a heart attack. He was fit, strong and relatively young – only 42 years old – and his death was a shock. ... […]
- Is influenza what’s circulating at Roselawn Condon School? on February 14, 2019 at 10:00 am
CINCINNATI — At least one ill student from the Roselawn Condon School tested positive for influenza A, according to the Cincinnati Health Department. The department is working with Cincinnati Public S... […]
via Bing News